Skip Navigation

Cardiovascular Research 2000 45(4):1019-1025; doi:10.1016/S0008-6363(99)00394-6
© 2000 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Zhou, Y. F.
Right arrow Articles by Epstein, S. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, Y. F.
Right arrow Articles by Epstein, S. E
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2000, European Society of Cardiology

Chronic non-vascular cytomegalovirus infection: effects on the neointimal response to experimental vascular injury

Yi Fu Zhoua,*, Matie Shoua, Robert F Harrellb, Zu Xi Yuc, Ellis F Ungerd and Stephen E Epsteina

aWashington Hospital Center, Vascular Biology Laboratory, Cardiovascular Research Institute, GHRB-217, 108 Irving Street, Washington, DC, USA
bCardiovascular Surgery Department, UCLA, School of Medicine, Los Angeles, CA, USA
cPathology Branch, NHLBI, National Institutes of Health, Bethesda, MD 20895, USA
dUS Food and Drug Administration, HFM-576, 1401 Rockville Pike, Rockville, MD 20852-1428, USA

* Corresponding author. Tel.: +1-202-877-2362; fax: +1-202-877-2363 yfz1{at}mhg.edu

Objective: Epidemiologic and mechanistic evidence implicates a role for cytomegalovirus (CMV) in atherogenesis. Recently, we demonstrated that CMV has the capacity to causally contribute to atherogenesis; acute infection of rats with rat CMV (RCMV) 1 day after carotid artery injury increased neointimal accumulation. Importantly, in the injured vessel infectious virus could not be detected and viral genome was present only transiently, suggesting that additional mechanisms play a role in the virus-induced exacerbation of the vascular injury response other than the changes caused by direct infection of vessel wall cells. The present investigation was designed to determine whether chronic persistent RCMV infection, more relevant to the clinical situation, also exacerbates the response to injury and, if so, whether similar mechanisms are operative. Methods: Sixty 3-week-old male Spraque–Dawley rats received an i.p. injection of either 106 TCID50 RCMV (Priscott strain) or normal saline. The left carotid artery was balloon-injured 3 months after infection. Rats were killed 6 weeks later. This model produces persistent infection, as demonstrated by presence of infectious virus in the salivary glands at time of sacrifice. Results: The neointima to media (N/M) ratio of the injured vessel was 41% greater in the RCMV-infected than in control rats (1.40±0.48 vs. 0.99±0.45; P=0.003). The aorta never contained infectious RCMV, and exhibited RCMV DNA, detected by PCR, only transiently. The persistent infection of non-vascular tissues was associated with increased serum levels of IL-2, IL-4 and IFN-{gamma}. Conclusions: CMV infection of young rats causes persistent infection of non-vascular tissues and increased cytokine levels. The neointimal response to subsequent vascular injury is increased, despite absence of virus from the vessel wall. These findings, as in acute infection following vascular injury, suggest that inflammatory and immune responses to chronic persistent CMV infection contribute to an exaggerated response to vascular injury.

KEYWORDS Arteries; Angioplasty; Cytokines; Infection/inflammation; Restenosis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
The Journal of RheumatologyHome page
G. F. MORA
Systemic Sclerosis: Environmental Factors
J Rheumatol, November 1, 2009; 36(11): 2383 - 2396.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. G. Alber, P. Vallance, and K. L. Powell
Enhanced Atherogenesis Is Not an Obligatory Response to Systemic Herpesvirus Infection in the ApoE-Deficient Mouse: Comparison of Murine {gamma}-Herpesvirus-68 and Herpes Simplex Virus-1
Arterioscler Thromb Vasc Biol, May 1, 2002; 22(5): 793 - 798.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Levi
CMV endothelitis as a factor in the pathogenesis of atherosclerosis
Cardiovasc Res, June 1, 2001; 50(3): 432 - 433.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.